Published in Antimicrob Agents Chemother on July 01, 1992
Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing. Antimicrob Agents Chemother (2009) 0.79
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Inactivation of herpes simplex viruses by nonionic surfactants. Antimicrob Agents Chemother (1978) 1.46
Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro. Antimicrob Agents Chemother (1985) 1.38
Virucidal effect of certain chemical contraceptives on Type 2 herpesvirus. Am J Obstet Gynecol (1976) 1.37
In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis. Antimicrob Agents Chemother (1985) 1.30
Time-lapse videomicroscopic study of in vitro wound closure in rabbit corneal cells. Invest Ophthalmol Vis Sci (1989) 1.13
In vitro effects of Emko on Neisseria gonorrhoeae and Trichomonas vaginalis. Am J Obstet Gynecol (1973) 0.99
In vitro activity of nonoxynol-9 on McCoy cells infected with Chlamydia trachomatis. Sex Transm Dis (1987) 0.88
Release of plasminogen activator by cultured corneal epithelial cells during differentiation and wound closure. Exp Eye Res (1986) 0.83
The effect of chemical intravaginal contraceptives and Betadine on Ureaplasma urealyticum. Contraception (1984) 0.81
Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture. J Clin Microbiol (1982) 3.64
Further Studies in Adult Rickets (Osteomalacia) and Foetal Rickets: (Section of Obstetrics and Gynaecology). Proc R Soc Med (1939) 3.56
Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50
Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun (1976) 3.44
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41
Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34
Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22
Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis (1989) 3.15
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00
A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49
Comparative susceptibility of eleven mammalian cell lines to infection with trachoma organisms. J Clin Microbiol (1975) 2.48
Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature (1994) 2.39
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J (1992) 2.28
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
Molecular cloning and expression of Chlamydia trachomatis major outer membrane protein antigens in Escherichia coli. Infect Immun (1985) 2.24
Clustering of mutations affecting alginic acid biosynthesis in mucoid Pseudomonas aeruginosa. J Bacteriol (1985) 2.23
TRIC type K, a new immunologic type of Chlamydia trachomatis. J Immunol (1974) 2.22
Approximately optimal one-parameter boundaries for group sequential trials. Biometrics (1987) 2.18
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis (1997) 2.06
Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03
Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02
Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test. J Clin Microbiol (1979) 1.96
Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis (1999) 1.91
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis (1998) 1.89
Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis (1993) 1.89
Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections. Am J Med (1990) 1.86
Serological response to Chlamydia pneumoniae infection. J Clin Microbiol (1990) 1.86
Neutralization of Chlamydia trachomatis cell culture infection by serovar-specific monoclonal antibodies. Infect Immun (1985) 1.84
B cell development in mice that lack one or both immunoglobulin kappa light chain genes. EMBO J (1993) 1.82
Rapid immunotyping of Chlamydia trachomatis with monoclonal antibodies in a solid-phase enzyme immunoassay. J Clin Microbiol (1985) 1.79
Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J Infect Dis (1987) 1.76
Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect Immun (1997) 1.74
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. II. A trachoma-LGV-specific antigen. J Immunol (1975) 1.73
Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72
Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA (1985) 1.66
An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis (1993) 1.63
Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol (1993) 1.63
Histopathology of Chlamydia trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket model. J Reprod Fertil (1989) 1.61
Detection of multiple serovars of Chlamydia trachomatis in genital infections. J Infect Dis (1985) 1.61
Bacteremia caused by Arcobacter cryaerophilus 1B. J Clin Microbiol (1997) 1.59
Autoantibody response to heat shock protein 70 in patients with heatstroke. Am J Med (2001) 1.57
Toxic effect of human polymorphonuclear leukocytes on Chlamydia trachomatis. Infect Immun (1982) 1.56
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis (1999) 1.54
Structural and antigenic analysis of Chlamydia pneumoniae. Infect Immun (1990) 1.52
Reticulate bodies as single antigen in Chlamydia trachomatis serology with microimmunofluorescence. J Clin Microbiol (1979) 1.50
The role of Chlamydia pneumoniae in atherosclerosis--recent evidence from animal models. Trends Microbiol (2000) 1.49
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol (1995) 1.45
Direct fluorescent monoclonal antibody stain for rapid detection of infant Chlamydia trachomatis infections. Pediatrics (1984) 1.43
Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol (1990) 1.42
Sequence analysis of the major outer membrane protein gene of Chlamydia pneumoniae. Infect Immun (1991) 1.40
Differential antimicrobial activity of human mononuclear phagocytes against the human biovars of Chlamydia trachomatis. J Immunol (1987) 1.40
Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis (1995) 1.37
Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am J Obstet Gynecol (1994) 1.37
Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in monkeys: a pathogenic mechanism of tubal damage. J Infect Dis (1994) 1.36
Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis (1995) 1.36
Evidence that the major outer membrane protein of Chlamydia trachomatis is glycosylated. Infect Immun (1991) 1.34
Ultrastructural study of Chlamydia trachomatis surface antigens by immunogold staining with monoclonal antibodies. Infect Immun (1987) 1.33
Experimental Chlamydia trachomatis salpingitis in mice: initial studies on the characterization of the leukocyte response to chlamydial infection. J Infect Dis (1989) 1.32
A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect Immun (1993) 1.29
Analysis of lymphocyte phenotype and cytokine activity in the inflammatory infiltrates of the upper genital tract of female macaques infected with Chlamydia trachomatis. J Infect Dis (1996) 1.29
Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis (2001) 1.28
Chlamydia trachomatis infections in men with Reiter's syndrome. Ann Intern Med (1984) 1.27
Molecular mechanisms for hyperinsulinaemia induced by overproduction of selenium-dependent glutathione peroxidase-1 in mice. Diabetologia (2008) 1.27
Further characterization of Chlamydia pneumoniae specific monoclonal antibodies. Microbiol Immunol (1995) 1.26
Cultures of Chlamydia trachomatis in mouse peritoneal macrophages: factors affecting organism growth. Infect Immun (1978) 1.25
Therapy of cervical chlamydial infection. Ann Intern Med (1982) 1.25
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol (1997) 1.24
Outer membrane complex proteins of Chlamydia pneumoniae. FEMS Microbiol Lett (1993) 1.23
Purification of a Chlamydia trachomatis-specific antigen by immunoadsorption with monospecific antibody. J Immunol (1977) 1.22
Binding of the glycan of the major outer membrane protein of Chlamydia trachomatis to HeLa cells. Infect Immun (1994) 1.22
Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol (1985) 1.21
Sequence analysis of the gene encoding the Chlamydia pneumoniae DnaK protein homolog. Infect Immun (1991) 1.21
Host response to primary Chlamydia trachomatis infection of the fallopian tube in pig-tailed monkeys. Fertil Steril (1983) 1.20
Isolation of a gene encoding a Chlamydia sp. strain TWAR protein that is recognized during infection of humans. Infect Immun (1989) 1.18
Chlamydial infection of subcutaneous fimbrial transplants in cynomolgus and rhesus monkeys. J Infect Dis (1987) 1.17
Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis (1994) 1.16
Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation (1998) 1.15
Immediate cytotoxicity of Chlamydia trachomatis for mouse peritoneal macrophages. Infect Immun (1978) 1.15